SCHEMBL1501351

SCHEMBL1501351

Nc1ccccc1C(=O)C=Cc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 1.00
CYP2C19 P33261 2/20 0.66
BCHE P06276 2/20 0.66
CYP1B1 Q16678 4/20 0.59
SMN1; SMN2 Q16637 4/20 0.58
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
CYP3A4 P08684 4/20 0.58
LMNA P02545 3/20 0.58
HPGD P15428 3/20 0.58
CYP2D6 P10635 2/20 0.58
ALOX12 P18054 2/20 0.58
NPC1 O15118 1/20 0.58
PKM P14618 1/20 0.58
NFKB1 P19838 1/20 0.58
RAB9A P51151 1/20 0.58
NFKB2 Q00653 1/20 0.58
RELA Q04206 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
HIF1A Q16665 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1501349 1.00 MAPT (1.00) MAPTCYP2C19BCHECYP1B1SMN1; SMN2
SCHEMBL27753446 0.88 MAPT (0.78) MAPTCYP2C19BCHECYP1B1SMN1; SMN2
SCHEMBL25190631 0.88 MAPT (0.78) MAPTCYP2C19BCHECYP1B1SMN1; SMN2
Phosphoric Acid SCHEMBL10747446 0.88 MAPT (0.78) MAPTCYP2C19BCHECYP1B1SMN1; SMN2
SCHEMBL25225496 0.88 MAPT (0.78) MAPTCYP2C19BCHECYP1B1SMN1; SMN2
Phosphoric Acid SCHEMBL10747444 0.88 MAPT (0.78) MAPTCYP2C19BCHECYP1B1SMN1; SMN2
SCHEMBL24214416 0.86 MAPT (0.76) MAPTCYP2C19CYP1B1SMN1; SMN2MEN1
SCHEMBL24215118 0.86 MAPT (0.76) MAPTCYP2C19BCHECYP1B1SMN1; SMN2
SCHEMBL11397615 0.86 MAPT (0.76) MAPTCYP2C19BCHECYP1B1SMN1; SMN2
SCHEMBL13347975 0.86 MAPT (0.76) MAPTCYP2C19BCHECYP1B1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102146216-B Monoazo and polyazo dyes favorable for health and synthesis method thereof UNIV ZHENGZHOU 2013-11-13 CN claimed
CN-102146216-A Monoazo and polyazo dyes favorable for health and synthesis method thereof UNIV ZHENGZHOU 2011-08-10 CN claimed
CN-102146216-B Monoazo and polyazo dyes favorable for health and synthesis method thereof UNIV ZHENGZHOU 2013-11-13 CN disclosed
CN-1984889-B Organometallic complex, luminous solid, organic EL element and organic EL display FUJI PHOTO FILM CO LTD 2011-08-24 CN disclosed
CN-102146216-A Monoazo and polyazo dyes favorable for health and synthesis method thereof UNIV ZHENGZHOU 2011-08-10 CN disclosed
CN-101357902-B Method for preparing N- formyl-2H-4chloroquinoline derivate UNIV ZHEJIANG TECHNOLOGY 2011-06-29 CN disclosed
EP-2291355-A2 NOVEL TETRAHYDROQUINOLINES AS AROMATASE INHIBITORS Panjab University (IN) 2011-03-09 EP disclosed
US-20100280070-A1 NOVEL TETRAHYDROQUINOLINES AS AROMATASE INHIBITORS AKKINEPALLY RAGHURAM RAO 2010-11-04 US disclosed
WO-2009087684-A2 NOVEL TETRAHYDROQUINOLINES AS AROMATASE INHIBITORS PANJAB UNIVERSITY (IN) 2009-07-16 WO disclosed
CN-101357902-A Method for preparing N- formyl-2H-4chloroquinoline derivate UNIV ZHEJIANG TECHNOLOGY (CN) 2009-02-04 CN disclosed
CN-1329354-C Fluorescent material, organic electroluminescent element and organic electroluminescent display FUJITSU LTD (JP) 2007-08-01 CN disclosed
CN-1984889-A Organometallic complex, luminous solid, organic EL element and organic EL display FUJI PHOTO FILM CO LTD (JP) 2007-06-20 CN disclosed
CN-1302087-C Light-emitting device and aromatic compound FUJI PHOTO FILM CO LTD (JP) 2007-02-28 CN disclosed
CN-1609163-A Fluorescent material, organic electroluminescent element and organic electroluminescent display FUJITSU LTD (JP) 2005-04-27 CN disclosed
EP-1279671-B1 Process for enantioselective epoxidation of alpha, beta-unsaturated enones and alpha, beta-unsaturated sulfones catalysed by polyamino acids BAYER CHEMICALS AG (DE) 2005-02-16 EP disclosed
CN-1527871-A Light emitting device and aromatic compound ��ʿ��Ƭ��ʽ���� 2004-09-08 CN disclosed
US-6770766-B2 QUATERNARY AMMONIUM OR PHOSPHONIUM PHASE TRANSFER CATALYST BAYER CHEMICALS AG (DE) 2004-08-03 US disclosed
US-20030087401-A1 Polyamino acid-catalyzed process for the enantioselective epoxidation of alpha,beta-unsaturated enones and alpha,beta-unsaturated sulfones LANXESS DEUTSCHLAND GMBH (DE) 2003-05-08 US disclosed
EP-1279671-A1 Process for enantioselective epoxidation of alpha, beta-unsaturated enones and alpha, beta-unsaturated sulfones catalysed by polyamino acids BAYER AG (DE) 2003-01-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100280070-A1 NOVEL TETRAHYDROQUINOLINES AS AROMATASE INHIBITORS CYP19A1, HSD17B11, CYP17A1 MAPT 4043/4885CYP2C19 16/4885BCHE 258/4885
US-20030087401-A1 Polyamino acid-catalyzed process for the enantioselective epoxidation of alpha,beta-unsaturated enones and alpha,beta-unsaturated sulfones COASY, SQLE, ELOVL1 MAPT 2989/4885CYP2C19 645/4885BCHE 2303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.